Controlled Release Drug Delivery Market, By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others (Micro-electromechanical Technology and Liposomes)), By Release Mechanism (Polymer Matrix Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, and Chemically Activated), By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, and Drug Eluting Stents) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI103719 | Publish Date: March 2024 | No. of Pages: 178

Global Controlled Release Drug Delivery Overview

Introduction:

Controlled release drug delivery system is used to release drug at a desired rate over a certain period of time which helps to maintain the therapeutic level in blood. For example, controlled release drug delivery system helps improve the efficacy ratio of the administered therapeutic. Uniform drug effect, less fluctuation in plasma drug levels, improved patient acceptance and compliance, and reduction in dosage frequency are some of the other benefits that a controlled release drug delivery system offers. Controlled drug delivery systems aim to maintain plasma concentration of drugs within the therapeutic window for a longer period of time. This helps to ensure sustained therapeutic action and for that reason an increasing interest in their development exist. For example, controlled release drug delivery system helps improve the efficacy ratio of the administered therapeutic uniform drug effect, less fluctuation in plasma drug levels, improved patient acceptance and compliance, and reduction in dosage frequency and dose amount are some of the other benefits that a controlled release drug delivery system offers. The controlled release drug delivery market accounted for US$ 40.37 billion in 2020 and is estimated to be US$ 83.02 billion by 2030 and is anticipated to register a CAGR of 7.50%.

Global Controlled Release Drug Delivery Dynamics

Advancements in drug delivery

Advancements in drug delivery systems that are mechanically strong, comfortable for patient, and capable of achieving high drug loading are major factors driving growth of the controlled release drug delivery market. In addition, controlled release drug delivery have various advantages like reduction in drug accumulation, reduced drug toxicity, stabilized medical condition due to more uniform drug levels, etc., which is boosting the growth of the global market. For instance, according to data published by National Cancer Institute, in May 2019, Doxorubicin, used on its own or in combination with other drugs, is an effective treatment for breast cancer and several other types of cancer. However, it is known to cause heart toxicities, such as arrhythmias and heart failure, in a small proportion of patients. However, potential disadvantages like possible toxicity or non-biocompatibility of the materials used are expected to hamper growth of the controlled release drug delivery market. Also, to this high cost of controlled release systems compared to traditional pharmaceutical formulations is expected to restrain growth of the controlled release drug delivery market to certain extent.

Increasing investment and R&D activities

Increasing investment and R&D activities by prominent players for development of cost effective controlled release drug delivery is expected to create new opportunities to players operating in this market over the forecast period. Controlled release technologies continue to be the preferred life-cycle management (LCM) approach by pharmaceutical companies, as they provide tangible benefits like improving patient compliance. There is also a clear interest in the industry to try unique polymers and technologies as a way to achieve performance-driven differentiation in the market and to produce high quality drug products costs-effectively.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Controlled Release Drug Delivery Segmentation

Controlled release drug delivery market is segmented based on technology, release mechanism, application, and region.

On the basis of technology, global market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others. On the basis of release mechanism, the global market is sub divided into polymer matrix based systems, micro reservoir partition controlled drug delivery systems, feedback regulated drug delivery systems, activation-modulated drug delivery systems and chemically activated. On the basis of application, the global market is segmented into metered dose inhalers, injectable, transdermal and ocular patches, infusion pumps, oral controlled-drug delivery systems, and drug eluting stents.

Regional Insights:                               

For detailed understanding of market dynamics, the controlled drug release drug delivery system market is analysed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analysed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. North America market is presumed to dominate in the controlled release drug delivery market with higher revenue share as compared to other regional markets, due to increasing government initiatives for development of controlled release drug delivery, presence of prominent market players in this region. Europe market accounts for second-largest revenue share in the controlled release drug delivery market which is followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is expected to witness fastest growth in terms of revenue due to increasing pharmaceutical infrastructural, investment and R&D activities by pharmaceutical and biopharmaceutical companies in countries in this region.                                    

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Technology- Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, and Others (Micro-electromechanical Technology and Liposomes)

By Release Mechanism- Polymer Matrix Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems And Chemically Activated

By Application- Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, And Drug Eluting Stents

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Controlled Drug Release Drug Delivery System Market, By Technology

  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Others (Micro-electromechanical Technology, Liposomes)

Controlled Drug Release Drug Delivery System Market, By Release Mechanism

  • Polymer Matrix Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated

Controlled Drug Release Drug Delivery System Market, By Application

  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Infusion Pumps
  •  Oral Controlled-Drug Delivery Systems
  • Drug Eluting Stents

Controlled Drug Release Drug Delivery System Market, By Region:

  • North America
    • Middle East & Africa
      • Middle East & Africa Controlled Drug Release Drug Delivery System Market, By Technology
      • Middle East & Africa Controlled Drug Release Drug Delivery System Market, By Release Mechanism
      • Middle East & Africa Controlled Drug Release Drug Delivery System Market, By Application
      • Middle East & Africa Controlled Drug Release Drug Delivery System Market, By Country
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa
    • Latin America
      • Latin America Controlled Drug Release Drug Delivery System Market, By Technology
      • Latin America Controlled Drug Release Drug Delivery System Market, By Release Mechanism
      • Latin America Controlled Drug Release Drug Delivery System Market, By Application
      • Latin America Controlled Drug Release Drug Delivery System Market, By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Asia Pacific
      • Asia Pacific Controlled Drug Release Drug Delivery System Market, By Technology
      • Asia Pacific Controlled Drug Release Drug Delivery System Market, By Release Mechanism
      • Asia Pacific Controlled Drug Release Drug Delivery System Market, By Application
      • Asia Pacific Controlled Drug Release Drug Delivery System Market, By Country
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Europe
      • Europe Controlled Drug Release Drug Delivery System Market, By Technology
      • Europe Controlled Drug Release Drug Delivery System Market, By Release Mechanism
      • Europe Controlled Drug Release Drug Delivery System Market, By Application
      • Europe Controlled Drug Release Drug Delivery System Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • North America Controlled Drug Release Drug Delivery System Market, By Technology
    • North America Controlled Drug Release Drug Delivery System Market, By Release Mechanism
    • North America Controlled Drug Release Drug Delivery System Market, By Application
    • North America Controlled Drug Release Drug Delivery System Market, By Country
      • U.S.
      • Canada

Global Controlled Release Drug Delivery Key Players

Some of the prominent players operating in the controlled drug release drug delivery system market include Depomed, Inc., Coating Place, Inc., Corium International Inc., Alza Corporation (Johnson & Johnson), Alkermes plc; Pfizer Inc., SKY Pharmaceuticals Pvt. Ltd.; Pfizer, Inc; Aradigm Corporation; and Capsugel healthcare pvt Ltd. These key players operating in this target market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes around the world. For instance, in 2016, Capsugel announced completion of acquisition of Xcelience and Powdersize, which aided the company to expand its existing resources with respect to its dosage form solutions business segment.

Global Controlled Release Drug Delivery Company Profile

  • Depomed, Inc.
    •  Capsugel healthcare pvt Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    •  Aradigm Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pfizer, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • SKY Pharmaceuticals Pvt. Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Pfizer Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Alkermes plc
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Alza Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Corium International Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Coating Place, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance

Global Controlled Release Drug Delivery Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Technology
      • Market Snippet, By Release Mechanism
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Market Trends
    • Merger and Acquisitions
    • Impact Analysis
    • PEST Analysis
    • Porter’s Analysis
  4. Market Segmentation, By Technology, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Wurster Technique
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Coacervation
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Micro Encapsulation
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Transdermal Targeted Delivery
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
    • Others (Micro-electromechanical Technology and Liposomes)
      • Overview
      • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029

Market Segmentation, By Release Mechanism, 2019 – 2029, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
    • Y-o-Y Growth Analysis (%), 2019 – 2029
    • Segment Trends
  • Polymer Matrix Based Systems
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Micro Reservoir Partition Controlled Drug Delivery Systems
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Feedback Regulated Drug Delivery Systems
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Activation-modulated Drug Delivery Systems
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Chemically Activated
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029

Market Segmentation, By Application, 2019 – 2029, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
    • Y-o-Y Growth Analysis (%), 2019 – 2029
    • Segment Trends
  • Metered Dose Inhalers
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Injectable
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Transdermal and Ocular Patches
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Infusion Pumps
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Oral Controlled-Drug Delivery Systems
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  • Drug Eluting Stents
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Market, By Region, 2019 – 2029, (US$ Bn)
    • Overview
      • Market Value and Forecast (US$ Bn), and Share Analysis (%), 2019 — 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Bn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Release Mechanism, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Bn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Release Mechanism, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Bn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Release Mechanism, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Bn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Release Mechanism, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Bn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Release Mechanism, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Application, 2019 – 2029
      • Market Size and Forecast (US$ Bn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Depomed Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Coating Place Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Corium International Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Alza Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Alkermes plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Pfizer Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • SKY Pharmaceuticals Pvt. Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Aradigm Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Pfizer Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Capsugel healthcare pvt Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
    • Analyst Views
  3. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The controlled release drug delivery market accounted for US$ 40.37 billion in 2020 and is estimated to be US$ 83.02 billion by 2030 and is anticipated to register a CAGR of 7.50%.

The Controlled Release Drug Delivery Market is projected to increase at a CAGR of 7.50% during the forecast.

controlled release drug delivery market is segmented based on technology, release mechanism, application, and region.

Increasing investment and R&D activities by prominent players for development of cost effective controlled release drug delivery is expected to create new opportunities to players operating in this market over the forecast period.